Preoperative localisation of parathyroid adenomas in patients with persistent hyperparathyroidism relies currently on a combination of ultrasonography, technetium sestamibi scintigraphy/single photon emission computed tomography (SPECT), magnetic resonance imaging and venous sampling of parathyroid hormone. This evidence concerns the gene PTH and parathyroid gland adenoma.